3QG-22969-17516
4 vaccinations
4 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 038 / NH
- Registered
- 2021-04-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
UPU-26134-39903
Child or adolescent in my care · Female · 2022-06-29
Timeline
-
2021-04-07
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Registered in v-safe
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-05
-
2021-07-29
Survey response — 3 months, dose 2MedDRA: Headache, Oropharyngeal pain — Feeling: FairFree text: Sore throat and headachesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-30
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2022-04-29
Survey response — 12 months, dose 2MedDRA: Cough, Gastroenteritis viral, Headache, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stomach flu, cold (cough, sore throat, congestion), headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-05-08
-
2022-09-08
Dose 4 — Moderna
-
2022-09-13
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Bruising at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-14
- 2022-10-20
- 2022-12-08
-
2023-03-09
Survey response — 6 months, dose 4MedDRA: Abortion induced, Foetal disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-09
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-09 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Sore throat and headaches
Release 11 — 12 months, dose 2
Symptoms: Stomach flu, cold (cough, sore throat, congestion), headache
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Bruising at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion induced | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Foetal disorder | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release